An interventional study of Animated Videos in Diabetic Retinopathy (DR) and Macular Edema (ME), sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.
Health literacy is a prevalent issue at Zuckerberg San Francisco General Hospital, particularly at the eye clinic where understanding of diagnoses and treatment plans largely affect vision outcomes. This study will determine whether video-based explanations, created in both English and Spanish, of diabetic retinopathy can improve knowledge concordance and follow up rates among patients in the eye clinic. Knowledge concordance and patient satisfaction will be assessed through digital surveys in Qualtrics.
778 studies on the registry are indexed under Diabetic Retinopathy; 142 are open to participants now.
This study's planned enrollment of 150 is above the median of 80 across 481 interventional studies indexed under Diabetic Retinopathy.
Browse Diabetic Retinopathy studies →University of California, San Francisco is the lead sponsor of 2,169 studies on the registry; 372 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 202 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Videos
Behavioral: Animated Videos
Control
Animated videos (in English and Spanish) that describe diabetic retinopathy.
Change in Knowledge Concordance Assessed through Validated Questionarres
Validated questionnaires in Qualtrics consisting of multiple choice questions and scales from 0 through 10 will be used to assess knowledge concordance before and after the patient's appointment. The change in concordance will be determined for each patient.
Time frame: 12 months
Follow Up Adherence, Assessed through Electronic Record Review
The number of scheduled follow-up appointments versus the number of attended follow-up appointments will be compared for each patient through electronic record review.
Time frame: 12 months
Diabetic Retinopathy Progression, Assessed through Electronic Health Record Review
Electronic health records and ocular imaging will be reviewed to determine whether patients' diabetic retinopathy has progressed or improved. The numbers of patients with mild, moderate, severe, and proliferative diabetic retinopathy will be compared between groups at the end of the study period.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Dec 2027, 15 months later.
Of 111 non-industry interventional studies with no phase under Diabetic Retinopathy, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's planned 15 months is below that.
Counting every sponsor, half of 126 studies reached it within 29 months; a quarter within 11 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →